Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Revenue 2010-2025 | AMGN

Amgen annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Amgen revenue for the quarter ending March 31, 2025 was $8.149B, a 9.43% increase year-over-year.
  • Amgen revenue for the twelve months ending March 31, 2025 was $34.126B, a 15.56% increase year-over-year.
  • Amgen annual revenue for 2024 was $33.424B, a 18.57% increase from 2023.
  • Amgen annual revenue for 2023 was $28.19B, a 7.09% increase from 2022.
  • Amgen annual revenue for 2022 was $26.323B, a 1.32% increase from 2021.
  
Amgen Annual Revenue
(Millions of US $)
2024 $33,424
2023 $28,190
2022 $26,323
2021 $25,979
2020 $25,424
2019 $23,362
2018 $23,747
2017 $22,849
2016 $22,991
2015 $21,662
2014 $20,063
2013 $18,676
2012 $17,265
2011 $15,582
2010 $15,053
2009 $14,642
Amgen Quarterly Revenue
(Millions of US $)
2025-03-31 $8,149
2024-12-31 $9,086
2024-09-30 $8,503
2024-06-30 $8,388
2024-03-31 $7,447
2023-12-31 $8,196
2023-09-30 $6,903
2023-06-30 $6,986
2023-03-31 $6,105
2022-12-31 $6,839
2022-09-30 $6,652
2022-06-30 $6,594
2022-03-31 $6,238
2021-12-31 $6,846
2021-09-30 $6,706
2021-06-30 $6,526
2021-03-31 $5,901
2020-12-31 $6,634
2020-09-30 $6,423
2020-06-30 $6,206
2020-03-31 $6,161
2019-12-31 $6,197
2019-09-30 $5,737
2019-06-30 $5,871
2019-03-31 $5,557
2018-12-31 $6,230
2018-09-30 $5,904
2018-06-30 $6,059
2018-03-31 $5,554
2017-12-31 $5,802
2017-09-30 $5,773
2017-06-30 $5,810
2017-03-31 $5,464
2016-12-31 $5,965
2016-09-30 $5,811
2016-06-30 $5,688
2016-03-31 $5,527
2015-12-31 $5,536
2015-09-30 $5,723
2015-06-30 $5,370
2015-03-31 $5,033
2014-12-31 $5,331
2014-09-30 $5,031
2014-06-30 $5,180
2014-03-31 $4,521
2013-12-31 $5,011
2013-09-30 $4,748
2013-06-30 $4,679
2013-03-31 $4,238
2012-12-31 $4,421
2012-09-30 $4,319
2012-06-30 $4,477
2012-03-31 $4,048
2011-12-31 $3,973
2011-09-30 $3,944
2011-06-30 $3,959
2011-03-31 $3,706
2010-12-31 $3,841
2010-09-30 $3,816
2010-06-30 $3,804
2010-03-31 $3,592
2009-12-31 $3,809
2009-09-30 $3,812
2009-06-30 $3,713
2009-03-31 $3,308
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $159.618B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $220.597B 16.47
Gilead Sciences (GILD) United States $138.711B 14.41
Vertex Pharmaceuticals (VRTX) United States $117.364B 0.00
Bristol Myers Squibb (BMY) United States $96.931B 6.49
GSK (GSK) United Kingdom $78.843B 9.44
CSL (CSLLY) Australia $76.680B 0.00
Regeneron Pharmaceuticals (REGN) United States $59.137B 14.35
Alnylam Pharmaceuticals (ALNY) United States $42.998B 0.00
Argenex SE (ARGX) Netherlands $33.284B 90.85
BioNTech SE (BNTX) Germany $26.025B 0.00
Royalty Pharma (RPRX) United States $20.347B 8.60
Biogen (BIIB) United States $19.516B 8.42
Insmed (INSM) United States $18.637B 0.00
Illumina (ILMN) United States $15.884B 30.13
Genmab (GNMSF) Denmark $13.545B 13.85
Incyte (INCY) United States $13.196B 100.25
Genmab (GMAB) Denmark $13.107B 14.70
Exelixis (EXEL) United States $12.081B 20.51
Moderna (MRNA) United States $11.711B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.964B 17.81
QIAGEN (QGEN) Netherlands $10.812B 21.04
Ascendis Pharma (ASND) Denmark $10.582B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.160B 0.00
Bio-Techne Corp (TECH) United States $8.337B 31.10
Blueprint Medicines (BPMC) United States $8.279B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.669B 0.00
Roivant Sciences (ROIV) United Kingdom $7.457B 0.00
Repligen (RGEN) United States $7.133B 79.85
Revolution Medicines (RVMD) United States $6.927B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.651B 6.53
Halozyme Therapeutics (HALO) United States $6.634B 12.70
Legend Biotech (LEGN) United States $6.599B 0.00
Guardant Health (GH) United States $6.217B 0.00
Nuvalent (NUVL) United States $5.781B 0.00
TG Therapeutics (TGTX) United States $5.761B 151.21
Telix Pharmaceuticals (TLX) Australia $5.583B 0.00
Anbio Biotechnology (NNNN) Germany $5.209B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $5.123B 0.00
Axsome Therapeutics (AXSM) United States $5.116B 0.00
Alkermes (ALKS) Ireland $4.782B 12.83
CRISPR Therapeutics AG (CRSP) Switzerland $4.462B 0.00
ADMA Biologics Inc (ADMA) United States $4.331B 32.39
Vaxcyte (PCVX) United States $4.292B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.258B 0.00
Akero Therapeutics (AKRO) United States $4.136B 0.00
Cytokinetics (CYTK) United States $4.104B 0.00
Zealand Pharma (ZLDPF) Denmark $4.102B 0.00
Krystal Biotech (KRYS) United States $4.085B 31.48
Zai Lab (ZLAB) China $3.942B 0.00
PTC Therapeutics (PTCT) United States $3.895B 6.78
Ultragenyx Pharmaceutical (RARE) United States $3.731B 0.00
Merus (MRUS) Netherlands $3.691B 0.00
Arcellx (ACLX) United States $3.656B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.555B 31.24
Avidity Biosciences (RNA) United States $3.538B 0.00
Ascentage Pharma Group - (AAPG) China $3.472B 0.00
Scholar Rock Holding (SRRK) United States $3.375B 0.00
Protagonist Therapeutics (PTGX) United States $3.142B 67.59
Viking Therapeutics (VKTX) United States $3.113B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.064B 0.00
Metsera (MTSR) United States $3.032B 0.00
Kymera Therapeutics (KYMR) United States $2.900B 0.00
Immunovant (IMVT) United States $2.873B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.735B 0.00
Alvotech (ALVO) Luxembourg $2.692B 15.40
Xenon Pharmaceuticals (XENE) Canada $2.561B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.432B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.334B 0.00
ImmunityBio (IBRX) United States $2.330B 0.00
Twist Bioscience (TWST) United States $2.258B 0.00
Apellis Pharmaceuticals (APLS) United States $2.240B 0.00
Ligand Pharmaceuticals (LGND) United States $2.193B 0.00
Denali Therapeutics (DNLI) United States $2.165B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.118B 0.00
Bavarian Nordic (BVNRY) Denmark $2.089B 11.04
Vericel (VCEL) United States $2.087B 1382.00
Agios Pharmaceuticals (AGIO) United States $2.047B 0.00
Apogee Therapeutics (APGE) United States $2.041B 0.00
CG Oncology (CGON) United States $2.034B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.002B 0.00
Beam Therapeutics (BEAM) United States $1.999B 0.00
NovoCure (NVCR) Jersey $1.993B 0.00
IDEAYA Biosciences (IDYA) United States $1.920B 0.00
Certara (CERT) United States $1.864B 34.82
Harmony Biosciences Holdings (HRMY) United States $1.844B 12.26
Disc Medicine (IRON) United States $1.842B 0.00
Amicus Therapeutics (FOLD) United States $1.832B 198.33
Belite Bio (BLTE) United States $1.809B 0.00
Sarepta Therapeutics (SRPT) United States $1.788B 0.00
Adaptive Biotechnologies (ADPT) United States $1.744B 0.00
GRAIL (GRAL) United States $1.711B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.699B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.645B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.640B 0.00
Vera Therapeutics (VERA) United States $1.508B 0.00
Biohaven (BHVN) United States $1.507B 0.00
89BIO (ETNB) United States $1.474B 0.00
Celldex Therapeutics (CLDX) United States $1.468B 0.00
Janux Therapeutics (JANX) United States $1.424B 0.00
ANI Pharmaceuticals (ANIP) United States $1.413B 14.56
Mesoblast (MESO) Australia $1.388B 0.00
Edgewise Therapeutics (EWTX) United States $1.369B 0.00
Travere Therapeutics (TVTX) United States $1.318B 0.00
Viridian Therapeutics (VRDN) United States $1.243B 0.00
Dynavax Technologies (DVAX) United States $1.220B 72.57
CureVac (CVAC) Germany $1.211B 5.87
Structure Therapeutics (GPCR) United States $1.172B 0.00
AbCellera Biologics (ABCL) Canada $1.119B 0.00
Intellia Therapeutics (NTLA) United States $1.111B 0.00
MannKind (MNKD) United States $1.100B 22.62
Novavax (NVAX) United States $1.095B 2.55
Pacira BioSciences (PCRX) United States $1.074B 10.23
WAVE Life Sciences (WVE) Singapore $1.050B 0.00
Liquidia Technologies (LQDA) United States $1.031B 0.00
Niagen Bioscience (NAGE) United States $0.991B 139.78
Cidara Therapeutics (CDTX) United States $0.965B 0.00
NeoGenomics (NEO) United States $0.952B 0.00
BGM Group (BGM) China $0.949B 0.00
Nurix Therapeutics (NRIX) United States $0.948B 0.00
Praxis Precision Medicines (PRAX) United States $0.943B 0.00
Spyre Therapeutics (SYRE) United States $0.934B 0.00
Mineralys Therapeutics (MLYS) United States $0.932B 0.00
Pharvaris (PHVS) Netherlands $0.932B 0.00
Sionna Therapeutics (SION) United States $0.921B 0.00
MiMedx (MDXG) United States $0.920B 22.25
Arcus Biosciences (RCUS) United States $0.910B 0.00
Oric Pharmaceuticals (ORIC) United States $0.908B 0.00
Anavex Life Sciences (AVXL) United States $0.902B 0.00
Zymeworks (ZYME) United States $0.897B 0.00
Geron (GERN) United States $0.892B 0.00
LENZ Therapeutics (LENZ) United States $0.871B 0.00
Cogent Biosciences (COGT) United States $0.844B 0.00
Oculis Holding AG (OCS) Switzerland $0.836B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
CorMedix Inc (CRMD) United States $0.786B 52.68
UniQure (QURE) Netherlands $0.782B 0.00
GH Research (GHRS) Ireland $0.782B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.774B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.751B 0.00
Vir Biotechnology (VIR) United States $0.751B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.741B 0.00
Replimune (REPL) United States $0.736B 0.00
Jyong Biotech (MENS) $0.731B 0.00
Gyre Therapeutics (GYRE) United States $0.731B 195.00
Pharming Group (PHAR) Netherlands $0.725B 0.00
ArriVent BioPharma (AVBP) United States $0.722B 0.00
AnaptysBio (ANAB) United States $0.702B 0.00
Trevi Therapeutics (TRVI) United States $0.701B 0.00
Nuvation Bio (NUVB) United States $0.698B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.682B 0.00
Immatics (IMTX) Germany $0.679B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.665B 0.00
Sana Biotechnology (SANA) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.631B 14.62
Autolus Therapeutics (AUTL) United Kingdom $0.625B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.622B 0.00
Tango Therapeutics (TNGX) United States $0.612B 0.00
Arbutus Biopharma (ABUS) United States $0.611B 0.00
Upstream Bio (UPB) United States $0.599B 0.00
Urogen Pharma (URGN) United States $0.598B 0.00
Dianthus Therapeutics (DNTH) United States $0.591B 0.00
Iovance Biotherapeutics (IOVA) United States $0.584B 0.00
Castle Biosciences (CSTL) United States $0.578B 39.24
Arvinas (ARVN) United States $0.577B 0.00
Sage Therapeutics (SAGE) United States $0.569B 0.00
MeiraGTx Holdings (MGTX) United States $0.556B 0.00
Keros Therapeutics (KROS) United States $0.545B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.535B 0.00
Tyra Biosciences (TYRA) United States $0.534B 0.00
Opthea (OPT) Australia $0.525B 0.00
Maze Therapeutics (MAZE) United States $0.519B 0.00
Myriad Genetics (MYGN) United States $0.519B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.515B 0.00
Septerna (SEPN) United States $0.508B 0.00
Kura Oncology (KURA) United States $0.503B 0.00
Bicara Therapeutics (BCAX) United States $0.502B 0.00
Celcuity (CELC) United States $0.494B 0.00
Abivax SA (ABVX) France $0.492B 0.00
Precigen (PGEN) United States $0.475B 0.00
ATyr Pharma (ATYR) United States $0.470B 0.00
Fortrea Holdings (FTRE) United States $0.468B 12.93
Cullinan Therapeutics (CGEM) United States $0.458B 0.00
Cytek Biosciences (CTKB) United States $0.457B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.456B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.448B 0.00
Kamada (KMDA) Israel $0.445B 26.69
REGENXBIO (RGNX) United States $0.432B 0.00
Rapport Therapeutics (RAPP) United States $0.431B 0.00
Zenas BioPharma (ZBIO) United States $0.428B 0.00
Rezolute (RZLT) United States $0.416B 0.00
PureTech Health (PRTC) United States $0.413B 0.00
MBX Biosciences (MBX) United States $0.412B 0.00
Erasca (ERAS) United States $0.411B 0.00
Prime Medicine (PRME) United States $0.403B 0.00
Tectonic Therapeutic (TECX) United States $0.394B 0.00
ITeos Therapeutics (ITOS) United States $0.389B 0.00
Eton Pharmaceuticals (ETON) United States $0.388B 0.00
Emergent Biosolutions (EBS) United States $0.386B 0.00
Vigil Neuroscience (VIGL) United States $0.381B 0.00
Solid Biosciences (SLDB) United States $0.378B 0.00
Fulcrum Therapeutics (FULC) United States $0.374B 0.00
Citius Oncology (CTOR) United States $0.374B 0.00
Terns Pharmaceuticals (TERN) United States $0.372B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.369B 0.00
Compass Therapeutics (CMPX) United States $0.362B 0.00
Northwest Biotherapeutics (NWBO) United States $0.359B 0.00
Humacyte (HUMA) United States $0.358B 0.00
Amarin (AMRN) Ireland $0.345B 0.00
Absci (ABSI) United States $0.343B 0.00
Prothena (PRTA) Ireland $0.340B 0.00
Benitec Biopharma (BNTC) United States $0.334B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.331B 0.00
Aura Biosciences (AURA) United States $0.325B 0.00
Astria Therapeutics (ATXS) United States $0.323B 0.00
XOMA Royalty (XOMA) United States $0.312B 0.00
Olema Pharmaceuticals (OLMA) United States $0.311B 0.00
Atea Pharmaceuticals (AVIR) United States $0.310B 0.00
Annexon (ANNX) United States $0.308B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.308B 0.00
Crescent Biopharma (CBIO) United States $0.304B 0.00
Abeona Therapeutics (ABEO) United States $0.300B 0.00
Lifecore Biomedical (LFCR) United States $0.298B 0.00
Cartesian Therapeutics (RNAC) United States $0.295B 0.00
Aardvark Therapeutics (AARD) United States $0.293B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.291B 59.12
Vanda Pharmaceuticals (VNDA) United States $0.288B 0.00
Inventiva S.A (IVA) France $0.285B 0.00
DBV Technologies S.A (DBVT) France $0.282B 0.00
Neurogene (NGNE) United States $0.282B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.279B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.278B 0.00
Foghorn Therapeutics (FHTX) United States $0.276B 0.00
Entrada Therapeutics (TRDA) United States $0.276B 8.98
Gossamer Bio (GOSS) United States $0.275B 0.00
Alpha Teknova (TKNO) United States $0.272B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.271B 0.00
Ocugen (OCGN) United States $0.271B 0.00
Verastem (VSTM) United States $0.267B 0.00
Palvella Therapeutics (PVLA) United States $0.263B 0.00
Allogene Therapeutics (ALLO) United States $0.262B 0.00
Candel Therapeutics (CADL) United States $0.250B 0.00
Sagimet Biosciences (SGMT) United States $0.249B 0.00
Prima BioMed (IMMP) Australia $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Cardiff Oncology (CRDF) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.238B 0.00
Adherex Technologies (FENC) United States $0.236B 0.00
Codexis (CDXS) United States $0.233B 0.00
Semper Paratus Acquisition (TVGN) United States $0.230B 0.00
Inhibrx Biosciences (INBX) United States $0.228B 0.13
ProQR Therapeutics (PRQR) Netherlands $0.224B 0.00
Adocia (ADOCY) France $0.216B 0.00
Monopar Therapeutics (MNPR) United States $0.215B 0.00
Editas Medicine (EDIT) United States $0.214B 0.00
ScPharmaceuticals (SCPH) United States $0.213B 0.00
SELLAS Life Sciences (SLS) United States $0.212B 0.00
Design Therapeutics (DSGN) United States $0.209B 0.00
CARGO Therapeutics (CRGX) United States $0.203B 0.00
AC Immune (ACIU) Switzerland $0.203B 0.00
Kodiak Sciences (KOD) United States $0.202B 0.00
Tvardi Therapeutics (TVRD) United States $0.201B 0.00
BioStem Technologies (BSEM) $0.201B 8.16
CytomX Therapeutics (CTMX) United States $0.200B 5.17
Bright Minds Biosciences (DRUG) United States $0.197B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.194B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.193B 0.00
EnGene Holdings (ENGN) Canada $0.191B 0.00
I-Mab (IMAB) United States $0.187B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.183B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.183B 0.00
Vor Biopharma (VOR) $0.181B 0.00
Alumis (ALMS) United States $0.178B 0.00
Voyager Therapeutics (VYGR) United States $0.177B 0.00
Puma Biotechnology (PBYI) United States $0.177B 4.62
Alpha Cognition (ACOG) Canada $0.171B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.170B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.161B 0.00
Nuvectis Pharma (NVCT) United States $0.157B 0.00
Instil Bio (TIL) United States $0.156B 0.00
Compugen (CGEN) Israel $0.155B 0.00
DiaMedica Therapeutics (DMAC) United States $0.153B 0.00
BioAge Labs (BIOA) United States $0.152B 0.00
Molecular Partners AG (MOLN) Switzerland $0.152B 0.00
Agenus (AGEN) United States $0.151B 0.00
Alector (ALEC) United States $0.150B 0.00
Black Diamond Therapeutics (BDTX) United States $0.148B 43.33
Ventyx Biosciences (VTYX) United States $0.144B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.140B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Rapt Therapeutics (RAPT) United States $0.132B 0.00
Actuate Therapeutics (ACTU) United States $0.132B 0.00
Greenwich LifeSciences (GLSI) United States $0.132B 0.00
Seer (SEER) United States $0.130B 0.00
Immuneering (IMRX) United States $0.129B 0.00
Skye Bioscience (SKYE) United States $0.129B 0.00
Fate Therapeutics (FATE) United States $0.128B 0.00
Caribou Biosciences (CRBU) United States $0.127B 0.00
Neumora Therapeutics (NMRA) United States $0.127B 0.00
Elicio Therapeutics (ELTX) United States $0.126B 0.00
Sangamo Therapeutics (SGMO) United States $0.125B 0.00
Nkarta (NKTX) United States $0.123B 0.00
Kyverna Therapeutics (KYTX) United States $0.122B 0.00
TuHURA Biosciences (HURA) United States $0.114B 0.00
BioHarvest Sciences (BHST) Canada $0.112B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.110B 0.00
Theratechnologies (THTX) Canada $0.109B 0.00
C4 Therapeutics (CCCC) United States $0.108B 0.00
Genelux (GNLX) United States $0.107B 0.00
HilleVax (HLVX) United States $0.106B 0.00
Contineum Therapeutics (CTNM) United States $0.103B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.103B 0.00
Jasper Therapeutics (JSPR) United States $0.102B 0.00
Tenaya Therapeutics (TNYA) United States $0.100B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
OKYO Pharma (OKYO) $0.098B 0.00
XBiotech (XBIT) United States $0.098B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.097B 0.00
Seres Therapeutics (MCRB) United States $0.095B 0.00
BeyondSpring (BYSI) United States $0.092B 0.00
Coherus Oncology (CHRS) United States $0.092B 0.00
Cellectis S.A (CLLS) France $0.092B 0.00
Adagene (ADAG) China $0.091B 0.00
Forte Biosciences (FBRX) United States $0.091B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.089B 0.00
Elutia (ELUT) United States $0.089B 0.00
Whitehawk Therapeutics (WHWK) United States $0.089B 0.00
Entera Bio (ENTX) Israel $0.087B 0.00
Invivyd (IVVD) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.085B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
TScan Therapeutics (TCRX) United States $0.083B 0.00
Cabaletta Bio (CABA) United States $0.081B 0.00
IGM Biosciences (IGMS) United States $0.079B 0.00
Inovio Pharmaceuticals (INO) United States $0.078B 0.00
Zura Bio (ZURA) United States $0.077B 0.00
TELA Bio (TELA) United States $0.076B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.074B 0.00
Oncolytics Biotech (ONCY) Canada $0.074B 0.00
Pliant Therapeutics (PLRX) United States $0.074B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.068B 0.00
Immunic (IMUX) United States $0.068B 0.00
Akoya Biosciences (AKYA) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.067B 0.00
Sutro Biopharma (STRO) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.064B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
MediciNova (MNOV) United States $0.062B 0.00
Alto Neuroscience (ANRO) United States $0.062B 0.00
Biomea Fusion (BMEA) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.060B 0.00
VistaGen Therapeutics (VTGN) United States $0.059B 0.00
Opus Genetics (IRD) United States $0.059B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
PDS Biotechnology (PDSB) United States $0.058B 0.00
Senti Biosciences (SNTI) United States $0.058B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Adlai Nortye (ANL) Cayman Islands $0.056B 0.00
Quantum Biopharma (QNTM) Canada $0.056B 0.00
INmune Bio (INMB) United States $0.056B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
ABVC BioPharma (ABVC) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.052B 0.00
Adicet Bio (ACET) United States $0.051B 0.00
Atara Biotherapeutics (ATRA) United States $0.049B 0.00
Celularity (CELU) United States $0.049B 0.00
CervoMed (CRVO) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Renovaro (RENB) United States $0.048B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
Applied Therapeutics (APLT) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Precision BioSciences (DTIL) United States $0.047B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
Annovis Bio (ANVS) United States $0.046B 0.00
Eyenovia (EYEN) United States $0.046B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
Medicus Pharma (MDCX) United States $0.044B 0.00
Scilex Holding (SCLX) United States $0.043B 0.00
Pluri (PLUR) Israel $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Shattuck Labs (STTK) United States $0.041B 0.00
PepGen (PEPG) United States $0.040B 0.00
Artiva Biotherapeutics (ARTV) United States $0.039B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.038B 0.00
Exicure (XCUR) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Alterity Therapeutics - (ATHE) Australia $0.036B 0.00
Clene (CLNN) United States $0.035B 0.00
Mersana Therapeutics (MRSN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Rein Therapeutics (RNTX) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
KALA BIO (KALA) United States $0.033B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Radiopharm Theranostics - (RADX) Australia $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Rani Therapeutics Holdings (RANI) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dyadic (DYAI) United States $0.028B 0.00
CAMP4 Therapeutics (CAMP) United States $0.027B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.026B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Passage Bio (PASG) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
ALX Oncology Holdings (ALXO) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Ovid Therapeutics (OVID) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Generation Bio (GBIO) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
CalciMedica (CALC) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Cognition Therapeutics (CGTX) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Cingulate (CING) United States $0.018B 0.00
Curis (CRIS) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Promis Neurosciences (PMN) Canada $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Rallybio (RLYB) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
NextCure (NXTC) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.011B 0.00
Equillium (EQ) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
GeoVax Labs (GOVX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Artelo Biosciences (ARTL) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
UNITY Biotechnology (UBX) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00